Pharmacogenetics (PGx)

Looks at variations in the human genome and ways in which genetic factors might influence how individuals respond to drugs.

PGx reduces direct medical costs per patient by $7,000 in the first 32 months ($26.2M annually per 10,000 patients)

Medicare over 32-month period. Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program, J. Pers. Med. 2022, 12, 421.

Precision Medication - The game changer

Seegnal is making Pharmacogenetics practical, enabling any clinician at the point of care to give precision medication in an instant

Probability of treatment efficacy based on generic profile

DNA test recommendation

Pre-test

Therapy recommendation based on Genetic results

Precision Medication

Post-test

Therapy conflicts, ensuring safe therapy free of adverse drug reaction

Alternative Drug Mechanism

Resolve

Seegnal is the only solution encompassing Precision Medication with patient personal condition to combat Adverse Drug Reaction prevention